Nauchno-Prakticheskaya Revmatologiya.
Ima-Press Publishing House.
Vol. 44.
2006.
P. 16-20
The results of double-blind comparative clinical trial of Herpovax and Vitaherpavac herpes simplex vaccines developed in Russia are discussed in the article. Positive clinical results achieved allow to recommend Vitaherpavac vaccine as a treatment of herpes simplex infections of different localization.